Point State Capital LP Ac Immune Sa Transaction History

Point State Capital LP

  • $5.69 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$7.35 - $11.7 $4.14 Million - $6.6 Million
-563,850 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$7.88 - $16.45 $3.44 Million - $7.17 Million
-436,150 Reduced 43.61%
563,850 $4.51 Million
Q2 2017

Aug 14, 2017
BUY
N/A
1,000,000
1,000,000 $8.8 Million

Others Institutions Holding ACIU

# of Institutions
41
Shares Held
29M
Call Options Held
92.9K
Put Options Held
46.3K
View Full List

About AC Immune SA

ACIU Quotes by TradingView
  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $299M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Point State Capital LP Portfolio

Follow Point State Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Point State Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email